---
figid: PMC9645811__elife-79940-fig4-figsupp3
pmcid: PMC9645811
image_filename: elife-79940-fig4-figsupp3.jpg
figure_link: /pmc/articles/PMC9645811/figure/fig4s3/
number: Figure 4â€”figure supplement 3
figure_title: Leftward peak shift in OPPhigh cells and accumulation of OPPlow cells
  occur over the course of drug treatment
caption: (A, B) Representative flow cytometry histograms of the O-propargyl-puromycin
  (OPP) assay from (A) cells treated with quizartinib or quizartinib/everolimus combo
  for shorter time points (3, 6, and 12 hr) either in RPMI or human bone marrow stromal
  cell (hBMSC-CM) and (B) cells treated with vehicle or everolimus only for 15 hr
  either in RPMI or hBMSC-CM.
article_title: Therapeutic resistance in acute myeloid leukemia cells is mediated
  by a novel ATM/mTOR pathway regulating oxidative phosphorylation.
citation: Hae J Park, et al. eLife. 2022;11:e79940.
year: '2022'

doi: 10.7554/eLife.79940
journal_title: eLife
journal_nlm_ta: eLife
publisher_name: eLife Sciences Publications, Ltd

keywords:
- AML
- drug resistance
- bone marrow
- Human

---
